CIK: 1722360 - Address: Assertio Holdings, Inc., 100 South Saunders Road, Suite 300, Lake Forest, IL 60045
37 results

TC

Stat

Stk

Ins

Fil

+d

+w

+m

+q

+h

+y

avg

Filing Date

T Date

Ticker

Issuer

Inc

Sector

Ind

Industry

Owner

oSt

Rel

Title

T

TVal

Price

L

Qty

oc

Own

H

r2y

r1y

r6m

r3m

r6w

r3w

r7d

r3d

f1d

f1w

f1m

f3m

f6m

f1y

3/8/23 16:05
3/6/23
TEVATeva Pharmaceutical Industries LtdL3HealthDrugPharmaceutical PreparationsStark David MatthewL3OEVP GCS.m-6309.550-66-963D
3/7/23 16:14
3/4/23
TEVATeva Pharmaceutical Industries LtdL3HealthDrugPharmaceutical PreparationsStark David MatthewL3OEVP GCM.dm00.00066999%69D
3/2/23 07:38
2/28/23
TEVATeva Pharmaceutical Industries LtdL3HealthDrugPharmaceutical PreparationsStark David MatthewL3OEVP GCM.d00.000633D
3/2/23 07:38
2/28/23
TEVATeva Pharmaceutical Industries LtdL3HealthDrugPharmaceutical PreparationsStark David MatthewL3OEVP GCS.d-6279.890-63-963D
7/29/22 07:02
7/28/22
TEVATeva Pharmaceutical Industries LtdL3HealthDrugPharmaceutical PreparationsStark David MatthewL3OEVP GCS-5269.040-58-953D
3/8/22 16:13
3/4/22
TEVATeva Pharmaceutical Industries LtdL3HealthDrugPharmaceutical PreparationsStark David MatthewL3OEVP GCM.dm00.0007261D
3/8/22 16:13
3/4/22
TEVATeva Pharmaceutical Industries LtdL3HealthDrugPharmaceutical PreparationsStark David MatthewL3OEVP GCS.dm-2417.450-32-3561D
3/2/22 07:54
2/28/22
TEVATeva Pharmaceutical Industries LtdL3HealthDrugPharmaceutical PreparationsStark David MatthewL3OEVP GCM.d00.0001862521D
3/2/22 07:54
2/28/22
TEVATeva Pharmaceutical Industries LtdL3HealthDrugPharmaceutical PreparationsStark David MatthewL3OEVP GCS.d-538.140-6-2321D
2/10/22 16:13
2/9/22
TEVATeva Pharmaceutical Industries LtdL3HealthDrugPharmaceutical PreparationsStark David MatthewL3OEVP GCM.d00.000139D
2/10/22 16:13
2/9/22
TEVATeva Pharmaceutical Industries LtdL3HealthDrugPharmaceutical PreparationsStark David MatthewL3OEVP GCS.d-559.060-6-399D
5/13/21 07:48
5/11/21
TEVATeva Pharmaceutical Industries LtdL3HealthDrugPharmaceutical PreparationsStark David MatthewL3OEVP GCM.d00.000383D
5/13/21 07:48
5/11/21
TEVATeva Pharmaceutical Industries LtdL3HealthDrugPharmaceutical PreparationsStark David MatthewL3OEVP GCS.d-38710.220-38-933D
3/8/21 16:12
3/4/21
TEVATeva Pharmaceutical Industries LtdL3HealthDrugPharmaceutical PreparationsStark David MatthewL3OEVP GCM.d00.000143D
3/8/21 16:12
3/4/21
TEVATeva Pharmaceutical Industries LtdL3HealthDrugPharmaceutical PreparationsStark David MatthewL3OEVP GCS.d-14710.570-14-823D
3/2/21 16:10
2/28/21
TEVATeva Pharmaceutical Industries LtdL3HealthDrugPharmaceutical PreparationsStark David MatthewL3OEVP GCM.d00.000183D
3/2/21 16:10
3/1/21
TEVATeva Pharmaceutical Industries LtdL3HealthDrugPharmaceutical PreparationsStark David MatthewL3OEVP GCS.d-20010.830-18-863D
2/17/21 16:09
2/14/21
TEVATeva Pharmaceutical Industries LtdL3HealthDrugPharmaceutical PreparationsStark David MatthewL3OEVP GCM.d00.00043D
2/17/21 16:09
2/16/21
TEVATeva Pharmaceutical Industries LtdL3HealthDrugPharmaceutical PreparationsStark David MatthewL3OEVP GCS.d-4411.120-4-573D
2/11/21 16:12
2/9/21
TEVATeva Pharmaceutical Industries LtdL3HealthDrugPharmaceutical PreparationsStark David MatthewL3OEVP GCM.d00.000133D
2/11/21 16:12
2/9/21
TEVATeva Pharmaceutical Industries LtdL3HealthDrugPharmaceutical PreparationsStark David MatthewL3OEVP GCS.d-82912.690-65-963D
3/19/20 07:38
3/17/20
TEVATeva Pharmaceutical Industries LtdL3HealthDrugPharmaceutical PreparationsStark David MatthewL3OEVP GCM.d00.00023833D
3/19/20 07:38
3/17/20
TEVATeva Pharmaceutical Industries LtdL3HealthDrugPharmaceutical PreparationsStark David MatthewL3OEVP GCS.d-177.160-2-443D
2/18/20 07:26
2/14/20
TEVATeva Pharmaceutical Industries LtdL3HealthDrugPharmaceutical PreparationsStark David MatthewL3OEVP GCM.d00.000173D
2/18/20 07:26
2/14/20
TEVATeva Pharmaceutical Industries LtdL3HealthDrugPharmaceutical PreparationsStark David MatthewL3OEVP GCS.d-20712.140-17-853D
2/11/20 07:06
2/9/20
TEVATeva Pharmaceutical Industries LtdL3HealthDrugPharmaceutical PreparationsStark David MatthewL3OEVP GCM.d00.000133D
2/11/20 07:06
2/10/20
TEVATeva Pharmaceutical Industries LtdL3HealthDrugPharmaceutical PreparationsStark David MatthewL3OEVP GCS.d-15312.240-13-813D
3/19/19 08:11
3/17/19
TEVATeva Pharmaceutical Industries LtdL3HealthDrugPharmaceutical PreparationsStark David MatthewL3OEVP GCM.d00.00023833D
3/19/19 08:11
3/18/19
TEVATeva Pharmaceutical Industries LtdL3HealthDrugPharmaceutical PreparationsStark David MatthewL3OEVP GCS.d-3916.430-2-443D
3/14/19 07:44
3/12/19
TEVATeva Pharmaceutical Industries LtdL3HealthDrugPharmaceutical PreparationsStark David MatthewL3OEVP GCM.d00.00024613D
3/14/19 07:44
3/12/19
TEVATeva Pharmaceutical Industries LtdL3HealthDrugPharmaceutical PreparationsStark David MatthewL3OEVP GCS.d-3915.820-2-453D
2/19/19 07:26
2/14/19
TEVATeva Pharmaceutical Industries LtdL3HealthDrugPharmaceutical PreparationsStark David MatthewL3OEVP GCM.d00.00043D
2/19/19 07:26
2/14/19
TEVATeva Pharmaceutical Industries LtdL3HealthDrugPharmaceutical PreparationsStark David MatthewL3OEVP GCS.d-7017.740-4-573D
3/20/18 16:16
3/17/18
TEVATeva Pharmaceutical Industries LtdL3HealthDrugPharmaceutical PreparationsStark David MatthewL3OEVP GCM.d00.00023833D
3/20/18 16:16
3/19/18
TEVATeva Pharmaceutical Industries LtdL3HealthDrugPharmaceutical PreparationsStark David MatthewL3OEVP GCS.d-4318.380-2-443D
3/14/18 16:35
3/12/18
TEVATeva Pharmaceutical Industries LtdL3HealthDrugPharmaceutical PreparationsStark David MatthewL3OEVP GCM.d00.00024583D
3/14/18 16:35
3/12/18
TEVATeva Pharmaceutical Industries LtdL3HealthDrugPharmaceutical PreparationsStark David MatthewL3OEVP GCS.d-4719.200-2-453D

DDerivative transaction in filing (usually option exercise)
MMultiple transactions in filing; earliest reported transaction date and weighted average transaction price
AAmended filing
EError detected in filing
S - SaleSale of securities on an exchange or to another person
S - Sale+OESale of securities on an exchange or to another person (after option exercise)
F - TaxPayment of exercise price or tax liability using portion of securities received from the company
P - PurchasePurchase of securities on an exchange or from another person
Return to top

Contact